GlassScriptPhysician profile
Gabriella Ursick
NPI 1912428426
$9,715.79
in general payments reported to CMS, 2019-2025
17 companies · $1,408 in 2025
The $1,408 reported for 2025 was more than what 93% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $262 · 2022: $2,094 · 2023: $2,821 · 2024: $3,132 · 2025: $1,408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,929 · Travel and Lodging: $3,431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,928.87 |
| Travel and Lodging | $3,430.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,732.89 | 2023-2025 | |
| Mentor Worldwide LLC | $1,540.56 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Sientra, INC. | $988.79 | 2022 | |
| Axogen | $284.44 | 2022-2023 | Avance Nerve Graft |
| Musculoskeletal Transplant Foundation INC. | $246.66 | 2021-2022 | |
| Allergan, INC. | $182.90 | 2022 | |
| Kerecis Limited | $161.89 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Rti Surgical, INC | $128.83 | 2023 | |
| Motiva USA, LLC | $125.00 | 2025 | |
| Medical Device Business Services, INC. | $95.60 | 2024 | Vistaseal |
| Revance Therapeutics, INC. | $70.87 | 2025 | Daxxify |
| Acera Surgical, INC. | $50.82 | 2024 | Restrata Wound Matrix |
| Ethicon US, LLC | $33.90 | 2024 | Ethicon, Stratafix |
| Davol INC. | $26.43 | 2025 | Galaflex Lite |
| Integra Lifesciences Corporation | $17.62 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $14.35 | 2024 | |
| Solventum Corporation | $14.24 | 2024 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriella Ursick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.